Abstract

BackgroundThis paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma.MethodsThe alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model.ResultsOne thousand five survival-associated alternative splicing events were identified. The prognostic genes included ATXN2L, MEIS1, IKBKB, COX4I1. Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1‐ and 3‐year survival rate.ConclusionOur data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets.

Highlights

  • Cancers are often associated with aberrant proteins

  • Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway

  • A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set

Read more

Summary

Introduction

Cancers are often associated with aberrant proteins. Cancer genome research showed the number of protein-coding genes was limited, which makes it difficult to account for the diverse proteomic phenotypes. Alternative RNA splicing is a key step of post-transcriptional gene expression regulation [1]. There were seven types of alternative splicing events: Exon Skip (ES), Mutually Exclusive Exons (ME), Retained Intron (RI), Alternate Promoter (AP), Alternate Terminator (AT), Alternate Donor site (AD), and Alternate Acceptor site (AA). Alternative splicing contributes to the protein diversity for 90% of human gene expression. AS provided targets of cancer treatment [3]. Characterization of the AS landscape provides a wealth of insight into cancers with excellent prognostic value. This paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.